These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
230 related items for PubMed ID: 33834622
1. Homozygous GDF2 nonsense mutations result in a loss of circulating BMP9 and BMP10 and are associated with either PAH or an "HHT-like" syndrome in children. Hodgson J, Ruiz-Llorente L, McDonald J, Quarrell O, Ugonna K, Bentham J, Mason R, Martin J, Moore D, Bergstrom K, Bayrak-Toydemir P, Wooderchak-Donahue W, Morrell NW, Condliffe R, Bernabeu C, Upton PD. Mol Genet Genomic Med; 2021 Dec; 9(12):e1685. PubMed ID: 33834622 [Abstract] [Full Text] [Related]
2. Characterization of GDF2 Mutations and Levels of BMP9 and BMP10 in Pulmonary Arterial Hypertension. Hodgson J, Swietlik EM, Salmon RM, Hadinnapola C, Nikolic I, Wharton J, Guo J, Liley J, Haimel M, Bleda M, Southgate L, Machado RD, Martin JM, Treacy CM, Yates K, Daugherty LC, Shamardina O, Whitehorn D, Holden S, Bogaard HJ, Church C, Coghlan G, Condliffe R, Corris PA, Danesino C, Eyries M, Gall H, Ghio S, Ghofrani HA, Gibbs JSR, Girerd B, Houweling AC, Howard L, Humbert M, Kiely DG, Kovacs G, Lawrie A, MacKenzie Ross RV, Moledina S, Montani D, Olschewski A, Olschewski H, Ouwehand WH, Peacock AJ, Pepke-Zaba J, Prokopenko I, Rhodes CJ, Scelsi L, Seeger W, Soubrier F, Suntharalingam J, Toshner MR, Trembath RC, Vonk Noordegraaf A, Wort SJ, Wilkins MR, Yu PB, Li W, Gräf S, Upton PD, Morrell NW. Am J Respir Crit Care Med; 2020 Mar 01; 201(5):575-585. PubMed ID: 31661308 [Abstract] [Full Text] [Related]
3. A rare homozygous missense GDF2 (BMP9) mutation causing PAH in siblings: Does BMP10 status contribute? Upton P, Richards S, Bates A, Niederhoffer KY, Morrell NW, Christian S. Am J Med Genet A; 2023 Jan 01; 191(1):228-233. PubMed ID: 36259599 [Abstract] [Full Text] [Related]
4. Pulmonary vascular phenotype identified in patients with GDF2 (BMP9) or BMP10 variants: an international multicentre study. Grynblat J, Bogaard HJ, Eyries M, Meyrignac O, Savale L, Jaïs X, Ghigna MR, Celant L, Meijboom L, Houweling AC, Levy M, Antigny F, Chaouat A, Cottin V, Guignabert C, Coulet F, Sitbon O, Bonnet D, Humbert M, Montani D, and the French PH Network PULMOTENSION Investigators. Eur Respir J; 2024 Apr 01; 63(4):. PubMed ID: 38514094 [Abstract] [Full Text] [Related]
5. Impact of heterozygous ALK1 mutations on the transcriptomic response to BMP9 and BMP10 in endothelial cells from hereditary hemorrhagic telangiectasia and pulmonary arterial hypertension donors. Al Tabosh T, Liu H, Koça D, Al Tarrass M, Tu L, Giraud S, Delagrange L, Beaudoin M, Rivière S, Grobost V, Rondeau-Lutz M, Dupuis O, Ricard N, Tillet E, Machillot P, Salomon A, Picart C, Battail C, Dupuis-Girod S, Guignabert C, Desroches-Castan A, Bailly S. Angiogenesis; 2024 May 01; 27(2):211-227. PubMed ID: 38294582 [Abstract] [Full Text] [Related]
6. Pediatric pulmonary arterial hypertension due to a novel homozygous GDF2 missense variant affecting BMP9 processing and activity. Chomette L, Hupkens E, Romitti M, Dewachter L, Vachiéry JL, Bailly S, Costagliola S, Smits G, Tillet E, Bondue A. Am J Med Genet A; 2023 Aug 01; 191(8):2064-2073. PubMed ID: 37249087 [Abstract] [Full Text] [Related]
7. Identification and validation of a novel pathogenic variant in GDF2 (BMP9) responsible for hereditary hemorrhagic telangiectasia and pulmonary arteriovenous malformations. Balachandar S, Graves TJ, Shimonty A, Kerr K, Kilner J, Xiao S, Slade R, Sroya M, Alikian M, Curetean E, Thomas E, McConnell VPM, McKee S, Boardman-Pretty F, Devereau A, Fowler TA, Caulfield MJ, Alton EW, Ferguson T, Redhead J, McKnight AJ, Thomas GA, Genomics England Research ConsortiumGenomics England, London, UK., Aldred MA, Shovlin CL. Am J Med Genet A; 2022 Mar 01; 188(3):959-964. PubMed ID: 34904380 [Abstract] [Full Text] [Related]
8. Novel homozygous BMP9 nonsense mutation causes pulmonary arterial hypertension: a case report. Wang G, Fan R, Ji R, Zou W, Penny DJ, Varghese NP, Fan Y. BMC Pulm Med; 2016 Jan 22; 16():17. PubMed ID: 26801773 [Abstract] [Full Text] [Related]
9. Reduced circulating BMP10 and BMP9 and elevated endoglin are associated with disease severity, decompensation and pulmonary vascular syndromes in patients with cirrhosis. Owen NE, Alexander GJ, Sen S, Bunclark K, Polwarth G, Pepke-Zaba J, Davenport AP, Morrell NW, Upton PD. EBioMedicine; 2020 Jun 22; 56():102794. PubMed ID: 32454407 [Abstract] [Full Text] [Related]
10. BMP10 functions independently from BMP9 for the development of a proper arteriovenous network. Choi H, Kim BG, Kim YH, Lee SJ, Lee YJ, Oh SP. Angiogenesis; 2023 Feb 22; 26(1):167-186. PubMed ID: 36348215 [Abstract] [Full Text] [Related]
11. BMP9 and BMP10: Two close vascular quiescence partners that stand out. Desroches-Castan A, Tillet E, Bouvard C, Bailly S. Dev Dyn; 2022 Jan 22; 251(1):178-197. PubMed ID: 34240497 [Abstract] [Full Text] [Related]
12. Hereditary Haemorrhagic Telangiectasia, an Inherited Vascular Disorder in Need of Improved Evidence-Based Pharmaceutical Interventions. Snodgrass RO, Chico TJA, Arthur HM. Genes (Basel); 2021 Jan 27; 12(2):. PubMed ID: 33513792 [Abstract] [Full Text] [Related]
13. Emerging roles of BMP9 and BMP10 in hereditary hemorrhagic telangiectasia. Tillet E, Bailly S. Front Genet; 2014 Jan 27; 5():456. PubMed ID: 25620979 [Abstract] [Full Text] [Related]
14. BMP9, but not BMP10, acts as a quiescence factor on tumor growth, vessel normalization and metastasis in a mouse model of breast cancer. Ouarné M, Bouvard C, Boneva G, Mallet C, Ribeiro J, Desroches-Castan A, Soleilhac E, Tillet E, Peyruchaud O, Bailly S. J Exp Clin Cancer Res; 2018 Aug 30; 37(1):209. PubMed ID: 30165893 [Abstract] [Full Text] [Related]
15. Regulation of the ALK1 ligands, BMP9 and BMP10. Li W, Salmon RM, Jiang H, Morrell NW. Biochem Soc Trans; 2016 Aug 15; 44(4):1135-41. PubMed ID: 27528761 [Abstract] [Full Text] [Related]
16. Homozygous GDF2-Related Hereditary Hemorrhagic Telangiectasia in a Chinese Family. Liu J, Yang J, Tang X, Li H, Shen Y, Gu W, Zhao S. Pediatrics; 2020 Aug 15; 146(2):. PubMed ID: 32669404 [Abstract] [Full Text] [Related]
17. BMP9 mutations cause a vascular-anomaly syndrome with phenotypic overlap with hereditary hemorrhagic telangiectasia. Wooderchak-Donahue WL, McDonald J, O'Fallon B, Upton PD, Li W, Roman BL, Young S, Plant P, Fülöp GT, Langa C, Morrell NW, Botella LM, Bernabeu C, Stevenson DA, Runo JR, Bayrak-Toydemir P. Am J Hum Genet; 2013 Sep 05; 93(3):530-7. PubMed ID: 23972370 [Abstract] [Full Text] [Related]
18. Expanding the Evidence of a Semi-Dominant Inheritance in GDF2 Associated with Pulmonary Arterial Hypertension. Gallego N, Cruz-Utrilla A, Guillén I, Bonora AM, Ochoa N, Arias P, Lapunzina P, Escribano-Subias P, Nevado J, Tenorio-Castaño J. Cells; 2021 Nov 15; 10(11):. PubMed ID: 34831401 [Abstract] [Full Text] [Related]
19. A heterodimer formed by bone morphogenetic protein 9 (BMP9) and BMP10 provides most BMP biological activity in plasma. Tillet E, Ouarné M, Desroches-Castan A, Mallet C, Subileau M, Didier R, Lioutsko A, Belthier G, Feige JJ, Bailly S. J Biol Chem; 2018 Jul 13; 293(28):10963-10974. PubMed ID: 29789425 [Abstract] [Full Text] [Related]
20. Effects of Modulating BMP9, BMPR2, and AQP1 on BMP Signaling in Human Pulmonary Microvascular Endothelial Cells. Lotsios NS, Keskinidou C, Dimopoulou I, Kotanidou A, Langleben D, Orfanos SE, Vassiliou AG. Int J Mol Sci; 2024 Jul 24; 25(15):. PubMed ID: 39125626 [Abstract] [Full Text] [Related] Page: [Next] [New Search]